RHHVF - Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products | Benzinga
Roche Holdings AG's (OTC: RHHBY) nine months sales increased by 1% (down 6% in CHF) to CHF 44.1 billion, even though the company had to compensate for the significant drop in sales of COVID-19 products and the biosimilar erosion (a total of CHF 4.0 billion or 9% of sales).
Excluding COVID-19 products, Group sales grew by 9%. Quarterly sales reached CHF14.3 billion, up 7% Y/Y.
Pharmaceuticals Division sales increased 9% to CHF 33.6 ...